Access to Medicines: Lifesaving TB medicines still out of reach for children in high-burden countries
September 3, 2021Geneva - The World Health Organization (WHO) recently released new rapid guidance recommending that children of all ages with drug-resistant tuberculosis (DR-TB) have access to all-oral treatment using the drugs bedaquiline and/or delamanid. However, adopting these new recommendations in high TB...
Read more
COVID-19 in India: Tackling tuberculosis in the middle of coronavirus pandemic
May 9, 2021By Aparna Iyer, Project Medical Referent, MSF Drug-Resistant Tuberculosis Project in MumbaiMSF’s drug-resistant tuberculosis (DR-TB) and HIV project is located in the M-East Ward, one of the TB high-burden areas in Mumbai. During the second wave, there was a high...
Read more
Tuberculosis: Sustainable solutions for children and adolescents at risk of drug-resistant TB
March 24, 2021They walked in single file through the narrow alleyways, winding away from their tin shack in Cape Town towards the health centre. Keitu – just 11 years old – carried her baby brother on her back since their mother was...
Read more
Tuberculosis: Trial of multidrug-resistant TB treatment ends enrolment early after independent board indicates new regimen is superior
March 24, 2021LONDON - A trial aiming to find a better treatment for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients early after its independent data safety and monitoring board indicated that the regimen being studied is superior to current care, and more...
Read more
Step UP For TB: Report shows new tests and drugs for world’s deadliest infectious disease remain out of reach
November 16, 2020MSF calls on governments and donors to step up and speed up TB testing and treatmentGeneva — As the COVID-19 pandemic threatens to derail the global response to tuberculosis (TB), Doctors Without Borders/Médecins Sans Frontières (MSF) called on governments to...
Read more
Hamari Awaaz: Addressing stigma in people living with multidrug-resistant tuberculosis in India
October 23, 2020[3d-flip-book mode="fullscreen" id="21871"][/3d-flip-book]
Read more
endTB trial: First patient enrolls for clinical trials of novel, short and all-oral regimens for multidrug-resistant tuberculosis in India
October 22, 2020Pune, India: Doctors Without Borders/ Médecins Sans Frontières (MSF) in collaboration with Indian Council for Medical Research (ICMR)- National AIDS Research Institute (NARI) and Department of Health Service, Government of Maharashtra is initiating two major clinical trials that aim at generating clinical evidence...
Read more
Tuberculosis: MSF welcomes WHO revision in TB guidelines and urges greater access and affordability in India to new regimen
August 4, 2020New Delhi, India: Doctors Without Borders/Medecins Sans Frontieres (MSF) has welcomed the revision made by the World Health Organisation (WHO) to its tuberculosis (TB) guidelines, allowing for safe use of a treatment regimen including both bedaquiline and delamanid for drug-resistant...
Read more
Access to medicines: Governments must scale up better TB treatment as J&J drops crucial drug price
July 6, 2020NEW YORK/GENEVA - The pharmaceutical corporation Johnson & Johnson (J&J) has announced a reduced price of US$1.50 [1] per day for the tuberculosis (TB) drug bedaquiline, which is an important step that should allow more people with drug-resistant forms of TB...
Read more
Mumbai: As the COVID-19 pandemic rages on, “I hope my treatment can continue and I can be cured.”
April 10, 2020“We spent hundreds of rupees in private health clinics to trying to cure my tuberculosis, but none of the medication worked. The treatment included daily painful injections with lots of side-effects like vomiting, fatigue, loss of appetite… and sometimes even...
Read more
World Tuberculosis Day: “It’s time” to end the suffering and accelerate access to all oral regimen
March 24, 2020Mumbai (India) - As of February 2020, the MSF private clinic in Govandi, Mumbai has initiated 188 drug-resistant tuberculosis (DR-TB) patients on treatment regimen which includes Bedaquiline and Delamanid. Globally, an estimated 10 million people fell ill with tuberculosis (TB) in 2018...
Read more
COVID-19: Avoiding a ‘second tragedy’ for those with TB
March 23, 2020As the world grapples with the coronavirus COVID-19 global pandemic, Doctors Without Borders/Médecins Sans Frontières (MSF) is concerned for vulnerable groups worldwide. People with tuberculosis (TB) are among the groups that may be particularly affected. Special attention will be needed to safeguard the continuity...
Read more
